| SOXS 1.79 4.07% | NVDA 177.19 -4.16% | ONMD 1.02 44.60% | NFLX 96.24 13.77% | JEM 0.096 3.90% | ENSC 0.6232 57.77% | BYND 0.9456 15.32% | PLUG 1.79 -6.28% | SOFI 17.76 -7.02% | NVD 7.53 8.50% | TZA 6.23 5.06% | NU 14.98 -0.53% | DUST 3.54 -3.50% | BITO 9.06 -2.78% | EOSE 5.695 -15.50% | XLF 51.43 -2.04% | BAC 49.83 -4.72% | AAL 13.07 -6.24% | MARA 8.94 5.80% | VEEA 0.5071 17.33% | SPY 685.99 -0.48% | SOXL 62.77 -3.93% | SLV 84.99 5.64% | XWEL 1.49 9.56% | QQQ 607.29 -0.32% | ONDS 10.08 -3.54% | BHAT 0.0495 -11.13% | PSKY 13.51 20.84% | INTC 45.61 0.33% | F 14.095 -2.19% | AAPL 264.18 -3.21% | XLE 55.92 1.58% | TQQQ 49.52 -1.06% | TSLA 402.51 -1.49% | HYG 80.72 -0.16% | TSDD 9.18 2.91% | TSLL 14.7 -3.10% | BATL 5.52 33.01% | RKT 18.19 2.36% | RXT 1.95 -14.47% | TLT 90.82 0.61% | TSLS 5.64 1.62% | WBD 28.17 -2.19% | PATH 10.73 0.14% | CRWV 79.56 -18.51% | IBIT 37.19 -2.80% | LQD 111.68 -0.04% | SOUN 8.6015 -4.21% | PLTR 137.19 0.92% | CPNG 19.08 1.98%

Coca-Cola Revenue Growth Misses Expectations as Company Prepares for CEO Transition

Coca-Cola (NYSE: KO) reported fourth-quarter revenue growth that came in below expectations, as the beverage giant said it was positioning the business for long-term success ahead of incoming CEO Henrique Braun’s tenure later this year.

Braun is set to take over leadership of the company, which includes brands such as Coca-Cola and Fairlife, at a time when the business has been adjusting package sizes to appeal to both price-sensitive consumers and health-conscious buyers.

The company continued to navigate persistent inflationary pressures affecting household spending, alongside shifting consumer preferences toward healthier options, a trend amplified by the popularity of weight-loss medications and the Make America Healthy Again movement under U.S. President Donald Trump’s administration. Coca-Cola also faced intensifying international competition, particularly as soda demand weakened in parts of Asia.

Still, outgoing CEO James Quincey said in a statement that he was encouraged by the company’s “resilience and momentum” throughout 2025.

Fourth-quarter unit case volumes rose 1%, matching the prior quarter and outperforming consensus expectations for a 0.66% decline. Price and mix increased 1%, well below analyst expectations of 4.62%.

Net revenue for the quarter totaled $11.8 billion, compared with projections of $12.03 billion. Comparable earnings per share edged up to $0.58.

Published on: February 10, 2026